SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma inks pact to acquire 60% stake in Vivaldis Health and Foods

25 Mar 2023 Evaluate

Sun Pharmaceutical Industries has entered into an agreement to acquire 60% shareholding in Vivaldis Health and Foods from its existing shareholders with remaining 40% shareholding to be acquired in future as per certain terms & conditions. Cost of acquisition is Rs 143.30 crore subject to customary closing adjustments for 60% shareholding. The said acquisition is expected to be completed by the end of May 2023.  

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1675.20 -17.95 (-1.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×